Elderberry for Common Cold

Verdict: Weak, disputed evidence for shorter colds

Elderberry does not appear to prevent colds, and while a few small trials hint it might shorten symptoms in people already sick, the evidence is weak, inconsistent, and clouded by industry funding. There is no reliable proof it works.

C 🟠 C Weak Evidence Disputed

🔬Why this grade7-layer evidence engine

The grade is weak because the entire literature is just a handful of small, conflicting trials. The most-cited positive result, a 312-person air-traveller RCT (PMID 27023596), found no reduction in how often people caught colds; its only benefit, shorter and milder colds, came from just 29 sick participants and was funded by a Sambucol manufacturer. A meta-analysis pooling four weak trials in 180 people (PMID 30670267) reported a large effect on symptom duration but blended cold and influenza outcomes.

Crucially, the best independent test undercuts the positive signal. A non-industry-funded emergency-room RCT (PMID 32929634) found elderberry no better than placebo, and a 2021 NIH-funded systematic review (PMID 33827515) concluded it likely does not prevent colds and that any duration benefit is uncertain. All benefits rest on self-reported symptom scores, not lab-confirmed infection.

Authoritative bodies are split to skeptical. The Cleveland Clinic sees no reason to take it, while Mayo Clinic notes only that some research suggests a roughly two-day shortening and says more research is needed. The FDA treats elderberry as a food flavoring, not a cold treatment, and the WHO notes there are no controlled clinical data. Raw or unripe elderberry is also unsafe unless properly heat-processed.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.41
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Disputed
Confidence
72%
Broadly consistent
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L5 Clinical bodiesAuthoritative stance
0.34
L2 PubMedPrimary literature
0.45
L3 MechanismPlausibility
0.45
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.50
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.412
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 1 個 hard + 1 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (4)L2 · primary research & systematic reviews

Elderberry Supplementation Reduces Cold Duration and Symptoms in Air-Travellers: A Randomized, Double-Blind Placebo-Controlled Clinical Trial
PMID: 27023596 2016 RCT (double-blind) n = 312
Finding: No significant difference in cold incidence (12 elderberry vs 17 placebo, p=0.4). Among the 29 travellers who did develop a cold, the placebo group had significantly longer total cold-episode days (117 vs 57, p=0.02) and higher cumulative symptom score (583 vs 247, p=0.05).
⚠️ Industry-funded Effect size: Cold-episode days 57 vs 117 (placebo); symptom score 247 vs 583 (placebo)
View on PubMed
Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: A meta-analysis of randomized, controlled clinical trials
PMID: 30670267 2019 統合分析 n = 180
Finding: Pooling 4 RCTs (180 participants), elderberry supplementation at symptom onset substantially reduced overall upper-respiratory symptom duration versus control, with a large mean effect size (~1.7); the effect was larger in influenza than in common cold.
Effect size: Large standardized mean effect (~1.7) for symptom-duration reduction
View on PubMed
Elderberry Extract Outpatient Influenza Treatment for Emergency Room Patients Ages 5 and Above: a Randomized, Double-Blind, Placebo-Controlled Trial
PMID: 32929634 2020 RCT (double-blind) n = 87
Finding: No statistically significant difference: symptom improvement 5.3 days (elderberry) vs 4.9 days (placebo); complete resolution 8.6 vs 8.7 days. Authors concluded there was no evidence elderberry benefits influenza duration or severity, contradicting earlier positive trials.
Academic Effect size: No significant difference (null)
View on PubMed
Elderberry for prevention and treatment of viral respiratory illnesses: a systematic review
PMID: 33827515 2021 系統性回顧
Finding: Across 5 RCTs, elderberry may not reduce the risk of developing a common cold; it may reduce cold duration and symptom severity but the evidence is uncertain. Overall quality of evidence on both benefits and harms is judged uncertain.
Government Effect size: Direction favourable for duration/severity; uncertain
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Cautious
ELDER FLOWERS, EXTRACT (SAMBUCUS CANADENSIS L. OR SAMBUCUS NIGRA L.) — 21 CFR 182.20 — FLAVOR ENHANCER, FLAVORING AGENT OR ADJUVANT source↗
L4b EU EFSA
Neutral
L4d TW TFDA / 衛福部
Neutral
接骨木莓(Sambucus nigra)果實得供食品使用;惟接骨木之葉、莖、樹皮、未成熟果實及種子含氰苷成分,不得供食品使用。 source↗
L4e WHO
Not addressed
Although no controlled clinical data are available, the descriptions in pharmacopoeias and traditional systems of medicine justify the use of Flos Sambuci as a diaphoretic for treatment of fever and chills, and as an expectorant for treatment of mild inflammation of the upper respiratory tract; also for symptomatic treatment of the common cold. source↗
L5a NIH Office of Dietary Supplements
Cautious
L5b Mayo Clinic
Cautious
Some research suggests that elderberry can shorten the length of the common cold by about two days and reduce the severity of cold symptoms. However, more research is needed to determine if these nonprescription remedies can ease cold symptoms. source↗
L5c Cleveland Clinic
Against
L5d Harvard Health
Cautious
L5e Specialty Society (condition-mapped)
Cautious
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬4 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-common-cold-INT-elderberry-001 繁體中文版 →